*August 2019* Dr. Pasi Janne
How Patients can Participate in EGFR Research: A conversation and Q&A with Dr. Pasi Janne, one of the world’s foremost experts in EGFR lung cancer research. Watch video.
We are a group of lung cancer patients with EGFR mutations who have developed resistance to at least one targeted treatment drug, or who face probable resistance in the future. Caregivers are also welcome. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.